plerixafor has been researched along with Myocardial Ischemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, M; Huang, K; Kishore, R; Losordo, DW; Miller, RJ; Qin, G; Tang, YL; Yan, D; Zhao, TC; Zhou, J | 1 |
| Kim, BJ; Kim, DK; Kim, JH; Kim, KW; Lee, MS; Oh, BJ; Park, KS; Park, SG; Yoon, KS | 1 |
| Chen, Y; Han, H; Hong, D; Qiao, H; Tong, Y; Wu, Y; Xu, W; Yang, J; Zhou, C | 1 |
| Brunner, S; David, R; Fischer, R; Franz, WM; Gerbitz, A; Huber, BC; Nathan, P; Segeth, A; Theiss, HD; Vallaster, M; Zaruba, MM | 1 |
4 other study(ies) available for plerixafor and Myocardial Ischemia
| Article | Year |
|---|---|
A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart.
Topics: Animals; Benzylamines; Bone Marrow Cells; Chemokine CXCL12; Chemotaxis; Cyclams; Gene Expression Regulation; Genes, Reporter; Green Fluorescent Proteins; Heterocyclic Compounds; Indoles; Male; Mesenchymal Stem Cells; Mice; Mice, Knockout; Myocardial Ischemia; Myocardium; Proto-Oncogene Proteins c-kit; Receptors, CXCR4; Signal Transduction; src-Family Kinases; Sulfonamides | 2015 |
Differences in donor CXCR4 expression levels are correlated with functional capacity and therapeutic outcome of angiogenic treatment with endothelial colony forming cells.
Topics: Animals; Benzylamines; Cell Movement; Cells, Cultured; Chemokine CXCL12; Cyclams; Endothelium, Vascular; Heterocyclic Compounds; Humans; Living Donors; Male; Mice; Mice, Nude; Myocardial Ischemia; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; Stem Cell Transplantation; Stem Cells; Umbilical Cord | 2010 |
Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia model.
Topics: Abietanes; Animals; Benzylamines; Bone Marrow Cells; Cell Movement; Chemokine CXCL12; Cyclams; Disease Models, Animal; Drugs, Chinese Herbal; Female; Heterocyclic Compounds; Male; Mesenchymal Stem Cells; Myocardial Infarction; Myocardial Ischemia; Myocardium; Phytotherapy; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Salvia miltiorrhiza; Stem Cell Transplantation; Up-Regulation | 2011 |
Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart.
Topics: Adult Stem Cells; Animals; Benzylamines; Cardiotonic Agents; Chemokine CXCL12; Cyclams; Dipeptidyl Peptidase 4; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Ischemia; Parathyroid Hormone; Protease Inhibitors; Receptors, CXCR4; Regenerative Medicine | 2011 |